Upgrade to SI Premium - Free Trial

Biomea Fusion, Inc. (BMEA)

0.69 -0.05 (6.76%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/3/26)

Latest Headlines

Form 8-K Biomea Fusion, Inc. For: Oct 13 October 14, 2026 6:02 AM - SEC Filing Biomea Fusion (BMEA) Reiterated at Market Outperform by Citizens on BMF-650 Ph1 Data October 14, 2026 4:10 AM - StreetInsider Biomea Fusion reports Phase 1 weight loss data for oral GLP-1 drug October 13, 2026 4:08 PM - StreetInsider Biomea Fusion Announces Phase 1 Results for BMF-650, its Investigational Next-Generation Oral Small Molecule GLP-1 Receptor Agonist October 13, 2026 4:08 PM - StreetInsider Biomea Fusion to release Phase I data for oral GLP-1 drug BMF-650 October 12, 2026 4:31 PM - StreetInsider Biomea Fusion to Announce Phase I Results for BMF-650, Its Next-Generation Oral Small-Molecule GLP-1 Receptor Agonist October 12, 2026 4:30 PM - Globe NewsWire Brookline Capital Markets Starts Biomea Fusion Inc. (BMEA) at Buy October 7, 2026 7:22 AM - StreetInsider Biomea Fusion (BMEA) Reiterated at Market Outperform by Citizens - Time to 'Revisit This Story' September 30, 2026 4:13 AM - StreetInsider Biomea Fusion cancels planned public offering citing market conditions September 23, 2026 7:04 AM - StreetInsider Biomea Fusion Announces Termination of Proposed Public Offering of Securities September 23, 2026 7:04 AM - Globe NewsWire Form 424B5 Biomea Fusion, Inc. September 22, 2026 4:08 PM - SEC Filing Biomea Fusion launches public offering of common stock and warrants September 22, 2026 4:05 PM - StreetInsider Biomea Fusion Announces Proposed Public Offering of Securities September 22, 2026 4:05 PM - StreetInsider Form 8-K Biomea Fusion, Inc. For: Sep 22 September 22, 2026 4:01 PM - SEC Filing Increasing unusual call volume: CYPH BMEA KHC DPRO CBRG NAVN TTAN RARE SOLZ TSSI AADX BEAM AVAV September 10, 2026 9:58 AM - StreetInsider Biomea Fusion, Inc. (BMEA) January 2.5 calls active September 8, 2026 5:30 AM - StreetInsider Increasing unusual call option volume: GPRO BMEA DPRO RARE INSW VSXY CHPT VRNS SYF EPYT September 8, 2026 4:44 AM - StreetInsider Biomea Fusion to Participate in Upcoming Investor Conferences September 3, 2026 8:00 AM - StreetInsider H.C. Wainwright on Biomea Fusion Inc. (BMEA) amid 17% Gain: 'Another step toward confirmatory Phase 2 data and T2D development strategy' August 24, 2026 9:43 AM - StreetInsider Biomea Fusion completes enrollment in Phase II diabetes trial August 24, 2026 7:03 AM - StreetInsider Biomea Fusion Announces Completion of Enrollment in COVALENT-211 Phase II Trial of Icovamenib in Insulin-Deficient Type 2 Diabetes August 24, 2026 7:00 AM - StreetInsider Biomea Fusion doses first patient in obesity combo drug study August 13, 2026 7:02 AM - StreetInsider Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity August 13, 2026 7:00 AM - StreetInsider Citi opens 90-day Positive catalyst watch on Biomea Fusion August 11, 2026 4:48 AM - StreetInsider Biomea Fusion, Inc. (BMEA) Tops Q2 EPS by 9c August 5, 2026 6:18 PM - StreetInsider Form 10-Q Biomea Fusion, Inc. For: Jun 30 August 5, 2026 4:13 PM - SEC Filing Form 8-K Biomea Fusion, Inc. For: Aug 05 August 5, 2026 4:11 PM - SEC Filing Biomea Fusion Reports Second Quarter 2026 Financial Results and Corporate Highlights August 5, 2026 4:06 PM - Globe NewsWire Full Article List